» Articles » PMID: 26961927

Best (but Oft-forgotten) Practices: the Design, Analysis, and Interpretation of Mendelian Randomization Studies

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2016 Mar 11
PMID 26961927
Citations 273
Authors
Affiliations
Soon will be listed here.
Abstract

Mendelian randomization (MR) is an increasingly important tool for appraising causality in observational epidemiology. The technique exploits the principle that genotypes are not generally susceptible to reverse causation bias and confounding, reflecting their fixed nature and Mendel’s first and second laws of inheritance. The approach is, however, subject to important limitations and assumptions that, if unaddressed or compounded by poor study design, can lead to erroneous conclusions. Nevertheless, the advent of 2-sample approaches (in which exposure and outcome are measured in separate samples) and the increasing availability of open-access data from large consortia of genome-wide association studies and population biobanks mean that the approach is likely to become routine practice in evidence synthesis and causal inference research. In this article we provide an overview of the design, analysis, and interpretation of MR studies, with a special emphasis on assumptions and limitations. We also consider different analytic strategies for strengthening causal inference. Although impossible to prove causality with any single approach, MR is a highly cost-effective strategy for prioritizing intervention targets for disease prevention and for strengthening the evidence base for public health policy.

Citing Articles

From Clinic to Mechanisms: Multi-Omics Provide New Insights into Cerebrospinal Fluid Metabolites and the Spectrum of Psychiatric Disorders.

Wen J, Li Y, Chen Y, Li Y, Yu B, Liu H Mol Neurobiol. 2025; .

PMID: 40085352 DOI: 10.1007/s12035-025-04773-0.


Mendelian randomization-based observational cohort study on drug targets: Impact of antihypertensive and lipid-lowering therapies on inflammatory cytokines.

Xin J, Xu Z, Zhang F, Sun Y, Wang X, Wu C Medicine (Baltimore). 2025; 104(10):e41771.

PMID: 40068040 PMC: 11903001. DOI: 10.1097/MD.0000000000041771.


Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Seagle H, Akerele A, DeCorte J, Hellwege J, Breeyear J, Kim J medRxiv. 2025; .

PMID: 40034783 PMC: 11875238. DOI: 10.1101/2025.02.18.25321035.


Exploring the causal association between circulating leukocyte count and IgA nephropathy based on two-sample Mendelian randomization: possible role of transitional B cells.

Fang F, Wang H, Luo J, Hong F Clin Exp Nephrol. 2025; .

PMID: 40011364 DOI: 10.1007/s10157-025-02646-3.


Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study.

Lee M, Burley K, Hazelwood E, Moore S, Lewis S, Goudswaard L Sci Rep. 2025; 15(1):3752.

PMID: 39885253 PMC: 11782597. DOI: 10.1038/s41598-025-86222-5.


References
1.
Xia J, May L, Koschinsky M . Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity. J Lipid Res. 2000; 41(10):1578-84. View

2.
Simo J, Joven J, Vilella E, Ribas M, Pujana M, Sundaram I . Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease. Thromb Haemost. 2001; 85(3):412-7. View

3.
Goring H, Terwilliger J, Blangero J . Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet. 2001; 69(6):1357-69. PMC: 1235546. DOI: 10.1086/324471. View

4.
Davey Smith G, Ebrahim S . Data dredging, bias, or confounding. BMJ. 2002; 325(7378):1437-8. PMC: 1124898. DOI: 10.1136/bmj.325.7378.1437. View

5.
Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View